Indivior PLC - Ordinary Shares (INDV)
Frequently Asked Questions About Indivior PLC - Ordinary Shares (INDV)
Does Indivior engage in corporate social responsibility initiatives?
Yes, Indivior engages in corporate social responsibility (CSR) initiatives aimed at increasing awareness about addiction and improving access to treatment. The company collaborates with various stakeholders, including non-profits and government agencies, to promote education and support programs that help individuals and families affected by substance use disorders.
Has Indivior faced any legal challenges?
Like many pharmaceutical companies, Indivior has faced legal challenges, particularly concerning patent disputes and allegations related to the marketing of its products. The company actively engages in legal proceedings to protect its interests and address claims made against it while continuing to prioritize patient care.
How can investors research Indivior's performance?
Investors can research Indivior's performance by reviewing its quarterly and annual financial reports, presentations, and press releases available on its investor relations website. They can also analyze stock performance through various financial news platforms, tracking analyst ratings and market sentiment regarding the company's potential growth and challenges.
How does Indivior contribute to addiction treatment?
Indivior contributes to addiction treatment through its innovative medications and patient-oriented approaches. The company not only provides approved pharmaceuticals for managing opioid dependence but also engages in educational initiatives, outreach programs, and collaborations with healthcare providers to enhance the support system for individuals struggling with addiction.
How does Indivior ensure the safety and efficacy of its products?
Indivior ensures the safety and efficacy of its products through rigorous clinical trials, adherence to regulatory guidelines, and ongoing post-marketing surveillance. The company collaborates closely with health authorities to comply with industry standards and continually monitor the performance of its medications in real-world settings.
Is Indivior involved in research and development?
Yes, Indivior is deeply involved in research and development (R&D) to advance new treatment options for addiction. The company invests significant resources in clinical trials and collaborations with research institutions to explore innovative medications that can better address substance use disorders and improve patient outcomes.
What are Indivior's future goals?
Indivior's future goals include expanding its portfolio of addiction treatment products, investing in innovative therapies, and enhancing global access to its medicines. The company seeks to strengthen its position as a leader in addiction care while contributing to comprehensive solutions that address the needs of patients and healthcare systems.
What are some of Indivior's major products?
Some major products offered by Indivior include Suboxone and Sublocade. Suboxone is available in both film and tablet forms and helps treat opioid dependency. Sublocade is a once-monthly injectable formulation that allows patients to manage their addiction more effectively by providing a consistent release of buprenorphine.
What does Indivior PLC do?
Indivior PLC specializes in the development and commercialization of innovative medicines for the treatment of addiction, primarily focusing on opioid use disorder. The company aims to reduce the burden of addiction by providing solutions that encompass both medication-assisted treatment and support for patients. Their flagship product, Suboxone, is utilized to help manage withdrawal symptoms and prevent relapse.
What is Indivior's mission statement?
Indivior's mission is to help patients with opioid dependence live better lives by providing them with the best possible treatment options and support. The company's dedication to innovation, patient education, and healthcare partnerships underscores its commitment to making a positive impact on addiction treatment worldwide.
What is the financial performance of Indivior?
Indivior's financial performance is influenced by the sales of its key products, particularly Suboxone and Sublocade. The company has experienced fluctuations in revenue due to market competition, regulatory changes, and the global opioid crisis, but it remains focused on expanding its offerings and reaching profitability through strategic initiatives and cost management.
What is the outlook for Indivior in the coming years?
The outlook for Indivior in the coming years is cautiously optimistic, driven by anticipated growth in demand for opioid addiction treatment and ongoing innovations in its product pipeline. While the company faces challenges, such as heightened competition and regulatory scrutiny, its commitment to addressing addiction holistically positions it for future success in the evolving healthcare landscape.
What is the stock symbol for Indivior PLC?
Indivior PLC is publicly traded on the NASDAQ stock exchange under the ticker symbol 'INDV'. Being a publicly listed company allows Indivior to attract investment and give shareholders a chance to benefit from its growth and success in the healthcare sector.
What markets does Indivior serve?
Indivior serves various markets globally, including the United States, Canada, and several countries in Europe and Asia. Their primary focus is on regions with high rates of opioid addiction, ensuring that patients worldwide have access to essential treatment options and support.
What role does Indivior play in addressing the opioid crisis?
Indivior plays a critical role in addressing the opioid crisis by providing effective treatment options and advocating for comprehensive strategies that encompass prevention, treatment, and recovery. Through its medications and educational initiatives, Indivior aims to reduce the stigma associated with addiction and improve access to care for those affected.
When was Indivior PLC founded?
Indivior PLC was founded in 2014 as a spin-off from Reckitt Benckiser Group plc, which decided to focus solely on its consumer health products. Since its establishment, Indivior has aimed to be a dedicated leader in the field of addiction treatment, contributing to public health through its innovative therapies.
Where is Indivior PLC headquartered?
Indivior PLC is headquartered in Richmond, Virginia, USA. This strategic location allows the company to position itself close to key markets and regulatory bodies involved in the healthcare and pharmaceutical industries.
Who are the key executives at Indivior?
Indivior's leadership team includes a group of experienced professionals in the pharmaceutical and healthcare sectors. Notable executives typically include the CEO, CFO, and heads of research and development, who bring a wealth of expertise to guide the company's strategy and operations in delivering addiction treatment solutions.
What is the current price of Indivior PLC - Ordinary Shares?
The current price of Indivior PLC - Ordinary Shares is 9.500
When was Indivior PLC - Ordinary Shares last traded?
The last trade of Indivior PLC - Ordinary Shares was at 2:13 pm EDT on April 3rd, 2025